Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MDB Capital Holdings, LLC - Class A common (NQ:MDBH)

2.860 -0.300 (-9.49%)
Streaming Delayed Price Updated: 2:50 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,239
Open 3.010
Bid (Size) 2.000 (1,100)
Ask (Size) 3.340 (300)
Prev. Close 3.160
Today's Range 2.860 - 3.010
52wk Range 2.450 - 5.500
Shares Outstanding 5,138,632
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice
From MDB Capital Holdings, LLC
Via GlobeNewswire

Performance

YTD
-18.3%
-18.3%
1 Month
-26.5%
-26.5%
3 Month
+1.4%
+1.4%
6 Month
-16.2%
-16.2%
1 Year
-24.1%
-24.1%

More News

Read More
News headline image
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
From PatentVest, Inc.
Via GlobeNewswire
News headline image
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
From PatentVest, Inc.
Via GlobeNewswire
News headline image
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
From PatentVest, Inc.
Via GlobeNewswire
News headline image
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
From PatentVest, Inc.
Via GlobeNewswire
News headline image
PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
From PatentVest, Inc.
Via GlobeNewswire
News headline image
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital Holdings Announces Transitions In Its Board of Directors
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital Holdings Provides Third Quarter 2025 Update
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $133B Cardiac Diagnostics Market
From PatentVest, Inc.
Via GlobeNewswire
News headline image
PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital Holdings Plans PatVest IPO ↗
Via The Motley Fool
Topics Initial Public Offering Intellectual Property
News headline image
MDB Capital Holdings Provides Second Quarter 2025 Update
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation
From PatentVest, Inc.
Via GlobeNewswire
News headline image
PatentVest Releases First-Ever Quantum Computing Rankings
From PatentVest, Inc.
Via GlobeNewswire
News headline image
MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time
From MDB Capital Holdings, LLC
Via GlobeNewswire
News headline image
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market
From PatentVest, Inc.
Via GlobeNewswire
News headline image
12 Financials Stocks Moving In Friday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is MDB Capital Holdings, LLC - Class A common publicly traded?
Yes, MDB Capital Holdings, LLC - Class A common is publicly traded.
What exchange does MDB Capital Holdings, LLC - Class A common trade on?
MDB Capital Holdings, LLC - Class A common trades on the Nasdaq Stock Market
What is the ticker symbol for MDB Capital Holdings, LLC - Class A common?
The ticker symbol for MDB Capital Holdings, LLC - Class A common is MDBH on the Nasdaq Stock Market
What is the current price of MDB Capital Holdings, LLC - Class A common?
The current price of MDB Capital Holdings, LLC - Class A common is 2.860
When was MDB Capital Holdings, LLC - Class A common last traded?
The last trade of MDB Capital Holdings, LLC - Class A common was at 06/12/26 02:50 PM ET
What is the market capitalization of MDB Capital Holdings, LLC - Class A common?
The market capitalization of MDB Capital Holdings, LLC - Class A common is 14.70M
How many shares of MDB Capital Holdings, LLC - Class A common are outstanding?
MDB Capital Holdings, LLC - Class A common has 15M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.